BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 15181253)

  • 1. In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology.
    Holtzman DM
    J Mol Neurosci; 2004; 23(3):247-54. PubMed ID: 15181253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy.
    Holtzman DM
    J Mol Neurosci; 2001 Oct; 17(2):147-55. PubMed ID: 11816788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo.
    DeMattos RB; Cirrito JR; Parsadanian M; May PC; O'Dell MA; Taylor JW; Harmony JA; Aronow BJ; Bales KR; Paul SM; Holtzman DM
    Neuron; 2004 Jan; 41(2):193-202. PubMed ID: 14741101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.
    DeMattos RB; O'dell MA; Parsadanian M; Taylor JW; Harmony JA; Bales KR; Paul SM; Aronow BJ; Holtzman DM
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10843-8. PubMed ID: 12145324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice.
    Fryer JD; Taylor JW; DeMattos RB; Bales KR; Paul SM; Parsadanian M; Holtzman DM
    J Neurosci; 2003 Aug; 23(21):7889-96. PubMed ID: 12944519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
    Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E and clusterin inhibit the early phase of amyloid-β aggregation in an in vitro model of cerebral amyloid angiopathy.
    Endo Y; Hasegawa K; Nomura R; Arishima H; Kikuta KI; Yamashita T; Inoue Y; Ueda M; Ando Y; Wilson MR; Hamano T; Nakamoto Y; Naiki H
    Acta Neuropathol Commun; 2019 Jan; 7(1):12. PubMed ID: 30691533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.
    Sadowski MJ; Pankiewicz J; Scholtzova H; Mehta PD; Prelli F; Quartermain D; Wisniewski T
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18787-92. PubMed ID: 17116874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
    Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
    Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model.
    Huynh TV; Wang C; Tran AC; Tabor GT; Mahan TE; Francis CM; Finn MB; Spellman R; Manis M; Tanzi RE; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2019 Oct; 14(1):37. PubMed ID: 31623648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release.
    Donner L; Fälker K; Gremer L; Klinker S; Pagani G; Ljungberg LU; Lothmann K; Rizzi F; Schaller M; Gohlke H; Willbold D; Grenegard M; Elvers M
    Sci Signal; 2016 May; 9(429):ra52. PubMed ID: 27221710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer's disease.
    Qi XM; Wang C; Chu XK; Li G; Ma JF
    BMC Neurosci; 2018 Jan; 19(1):2. PubMed ID: 29370749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.
    McCarron MO; Nicoll JA; Stewart J; Ironside JW; Mann DM; Love S; Graham DI; Dewar D
    J Neuropathol Exp Neurol; 1999 Jul; 58(7):711-8. PubMed ID: 10411341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice.
    de Retana SF; Marazuela P; Solé M; Colell G; Bonaterra A; Sánchez-Quesada JL; Montaner J; Maspoch D; Cano-Sarabia M; Hernández-Guillamon M
    Alzheimers Res Ther; 2019 May; 11(1):42. PubMed ID: 31077261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice.
    Montoliu-Gaya L; Güell-Bosch J; Esquerda-Canals G; Roda AR; Serra-Mir G; Lope-Piedrafita S; Sánchez-Quesada JL; Villegas S
    Biochem Pharmacol; 2018 Sep; 155():380-392. PubMed ID: 30026023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.